10.80
-0.09(-0.83%)
Currency In USD
| Previous Close | 10.89 |
| Open | 10.96 |
| Day High | 11.15 |
| Day Low | 10.52 |
| 52-Week High | 19 |
| 52-Week Low | 9.45 |
| Volume | 294,679 |
| Average Volume | 952,116 |
| Market Cap | 678.36M |
| PE | 12 |
| EPS | 0.9 |
| Moving Average 50 Days | 12.47 |
| Moving Average 200 Days | 12.47 |
| Change | -0.09 |
If you invested $1000 in aTyr Pharma, Inc. (LIFE) 10 years ago, it would be worth $176.13 as of February 21, 2026 at a share price of $10.8. Whereas If you bought $1000 worth of aTyr Pharma, Inc. (LIFE) shares 5 years ago, it would be worth $2,093.02 as of February 21, 2026 at a share price of $10.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product
GlobeNewswire Inc.
Jan 07, 2026 1:01 PM GMT
AUSTIN, Texas and DES MOINES, Iowa, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced a partnership with North American Company for Life and
Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution
GlobeNewswire Inc.
Dec 18, 2025 1:01 PM GMT
AUSTIN, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company democratizing access to life insurance, today announced a partnership with Aflac Incorporated (NYSE: AFL), a leading provider of supplemental health
Ethos Files Registration Statement for Proposed Initial Public Offering
GlobeNewswire Inc.
Sep 26, 2025 5:50 PM GMT
AUSTIN, Texas, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it filed a registration statement on Form S-1 with the U.S. Securities a